Climara Pro
Product Images NDC 54868-5570

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Climara Pro (NDC 54868-5570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Climara Pro Individual Carton (5570)

Label for Climara Pro transdermal system patches, each containing 0.045 mg and 0.015 mg strengths. The label includes lot number, expiration date (01/60), distributor Physicians Total Care, Inc., and a barcode. Manufactured by 3M Drug Delivery Systems in Northridge, CA.*

FDA Label Image

Structural Formula (Ca88204e 2f10 44b1 89c2 7148daa57302 01)

Chemical structure diagrams of Estradiol (E2) and Levonorgestrel (LNG), the active ingredients in Climara Pro. The diagram shows the molecular structures with labeled functional groups for each compound.*

FDA Label Image

Climara Pro System (Ca88204e 2f10 44b1 89c2 7148daa57302 02)

An instructional diagram depicting the three layers of a product component: (1) Film Backing, (2) Drug-in-Adhesive Layer, and (3) Protective Liner. This likely illustrates the structure of the Climara Pro transdermal patch.*

FDA Label Image

Figure 1 (Ca88204e 2f10 44b1 89c2 7148daa57302 03)

A line graph showing baseline unconjugated estradiol serum concentration (pg/mL) over time (hours). The curve rises sharply from 0 to about 24 hours, peaks, then gradually decreases with some fluctuations until 168 hours.*

FDA Label Image

Figure 2 (Ca88204e 2f10 44b1 89c2 7148daa57302 04)

A line graph depicting levonorgestrel serum concentration (ng/mL) over time (hours). The x-axis represents time in hours from 0 to 168, and the y-axis shows levonorgestrel serum concentration ranging from 0 to 250 ng/mL. The data points indicate serum concentration peaks and variations throughout the 168-hour period.*

FDA Label Image

Figure 3 (Ca88204e 2f10 44b1 89c2 7148daa57302 05)

A bar chart comparing the percentage values of Climara Pro versus Estradiol 44 mg over 13 cycles. The x-axis represents the cycle number from 1 to 13, and the y-axis shows the percentage from 0 to 70 percent. White bars represent Estradiol 44 mg, and shaded bars represent Climara Pro, with white bars generally higher across cycles.*

FDA Label Image

Figure 4 (Ca88204e 2f10 44b1 89c2 7148daa57302 06)

A line graph comparing the percentage change in total lumbar BMD from baseline over multiple cycles between a drug identified as 4.0mcg E2 and a placebo. The x-axis represents treatment cycles (Baseline, 6, 13, 19, 26 cycles) and the y-axis shows percentage change from baseline. Error bars indicate variability at each point for both groups.*

FDA Label Image

Opening The Pouch (Ca88204e 2f10 44b1 89c2 7148daa57302 07)

An instructional line drawing depicting hands demonstrating the use or application of a product, possibly indicating how to open or prepare it. The image shows detailed hand positioning and finger movements without text or other visual elements.*

FDA Label Image

Applying The Patch (Ca88204e 2f10 44b1 89c2 7148daa57302 08)

An instructional illustration showing a person applying a transdermal patch to the lower abdomen. The image demonstrates placement of the patch on the skin for medication delivery.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.